James Huang, Director, 10% Owner at WINDTREE THERAPEUTICS INC /DE/ (WINT), bought 400 shares at $3.84 ($2K) on 2020-02-18, disclosed to the SEC on 2020-02-20.
Open-market purchase of $2k WINT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ATRA | SELL | 2026-01-14 | $489K | — | Filing → |
| ATRA | BUY | 2025-07-21 | $373K | — | Filing → |
| CASI | BUY | 2022-09-08 | $304K | — | Filing → |